News from the ECOG-ACRIN Cancer Research Group
September 14, 2020
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, August/September 2020

Welcome to the News From ECOG-ACRIN blog; COVID-19 month six reflections; clinical trial enrollment continues to improve; EA Cancer Research Advocates Committee adds five new members
September 14, 2020
Lungs

Now Enrolling: EAQ172 for Treatment of Lung Inflammation in Patients with Any Type of Cancer

This phase II trial by EA's Cancer Control and Survivorship Committee is comparing two promising pneumonitis treatments for patients receiving PD-1/PD-L1 therapy
September 14, 2020
PrECOG logo

Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)

A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
September 14, 2020
Woman virtual presentation

2020 Young Investigator Symposium (A Virtual Event)

Up to eight young investigators will present their work at the annual Young Investigator Symposium, taking place during the Virtual Fall 2020 Group Meeting
September 14, 2020
Ingrid Mayer, MD

Trial Spotlight: Ingrid Mayer on Study EA1131 for Triple-Negative Breast Cancer, Including Men

This is the only study that is currently designed to test the ability to improve long-term outcomes by refining early-setting triple-negative breast cancer chemotherapy without exposing ALL patients to more toxicity preoperatively